Company Overview

Development Stage

About the Company

Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a core member of Guangzhou Pharmaceutical Holdings Limited, a Fortune 500 company. It is a high-tech enterprise specializing in the research, development, production, and sales of medicinal lipid raw materials and excipients, specialty APIs, health foods, and foods for special medical purposes. The company has been honored as a national engineering research center for modern Chinese medicine innovative R&D platforms and technologies, undertaking over 100 government science and technology projects, including major special projects for modern industrialization of traditional Chinese medicine. It has focused on solving key bottlenecks in the industry, such as outdated pharmaceutical process technologies and lack of high-end formulation excipients, and serves as a benchmark for the commercialization of scientific and technological achievements in China, exemplifying how state-owned enterprises create original technology sources. Baiyunshan Hanfang has been selected as a benchmark ''Science and Enterprise Reform'' company by the State-owned Assets Supervision and Administration Commission of the State Council, recognized as a specialized and innovative ''Little Giant'' enterprise by the Ministry of Industry and Information Technology, awarded the title of ''Green Factory'', and has received the ''National May Day Labor Certificate'' and a gold medal at the International Exhibition of Inventions in Geneva.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Recruitment Overview / Current Status (13 open positions)

Manage
N/A
Growth Rate
Year-by-Year Hiring: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Master's 5
Note: How fast is hiring at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. growing? 2026: 23 openings, 2024: 10 openings, 2023: 10 openings, 2022: 4 openings, 2021: 30 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. growing? Master's recruitment over the years: 2026: 6 openings, 2024: 2 openings, 2023: 3 openings, 2022: 1 openings.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2022 — same as 2021
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. growing? Doctorate recruitment over the years: 2022: 1 openings, 2021: 1 openings.

— What Are the Salaries Like? (20 records)

Manage
salary range: 6K - 50K, 75% of roles pay ¥6-15K
Note: salary statistics are based on 20 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.?75% of positions earn 6-15K, Undergraduate salary: ¥。经营管理类 average salary ¥12.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.? We provide: 工艺员,店长,操作员,研发人员,销售,qa,qc,司机,工艺技术,市场,电气,组长,自动化,运营. Click to view detailed salary analysis by job.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 经营管理类
    26.1% of total 26.1%
  • 工厂生产类
    21.7% of total 21.7%
  • 技工类
    21.7% of total 21.7%
  • 其他(研发和技术类)
    13% of total 13%

Education

  • 本科
    47.8% of total 47.8%
  • 硕士
    26.1% of total 26.1%
  • 大专
    17.4% of total 17.4%
  • 高中
    8.7% of total 8.7%

Experience

  • 不限
    87% of total 87%
  • 3-5年
    8.7% of total 8.7%
  • 1-3年
    4.3% of total 4.3%
View Detailed Analysis

What does Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. require? Who is Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. hiring? recruitment: 经营管理类占比最多占26.1%,其次是工厂生产类占21.7%. What education can get in at ? 本科占比最多占47.8%,其次是硕士占26.1%. High education required at ? 硕士占26.1%. Work experience required at ? 不限占比最多占87%,其次是3-5年占8.7%. Where are the job locations at ? 广州占比最多占95.7%,其次是北京占4.3%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 36,000万(元)
Legal Representative: 袁诚
Date Established:
Credit Code: 914401017124186087
Registered Address: 广州市从化温泉大道8号

Partners & Suppliers

从采芝林采购中药材 Source
供应商 集团内部关联交易
从陈李济采购中药材 Source
供应商 集团内部关联交易
向白云山何济公提供中药提取物 Source
合作客户 集团内部关联交易
向白云山光华提供中药提取物 Source
合作客户 集团内部关联交易
向白云山奇星提供中药提取物 Source
合作客户 集团内部关联交易

People who follow this company also follow

Competitors (Similar Companies)

商业物业 政府物业 住宅物业 环卫
“National Key Leading Enterprise in Agricultural Industrialization”
化妆品 面膜 ODM 生产
苯乙烯 聚乙烯/PE 乙酸丁酯 乙酸
塑料制品 薄膜 塑料薄膜 HDPE
塑料制品 薄膜 周转箱 塑料包装制品
“做全球优秀的化学素材供应商”
腐乳 食品制造 婴幼儿辅食 饮料
“Overall solutions for clinical laboratories”
网络招聘 委托招聘 猎头 招聘服务
“Innovative drug R&D”
“Member unit of the National Plastics Standardization Technical Committ”
维生素 医药 大健康 药妆
“Healthy and fashionable every day”
散热器 车身覆盖件 塑胶件 水箱

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates